Related references
Note: Only part of the references are listed.Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance
Melanie A. Krook et al.
BRITISH JOURNAL OF CANCER (2021)
Current experimental human tissue-derived models for prostate cancer research
Manabu Kato et al.
INTERNATIONAL JOURNAL OF UROLOGY (2021)
Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1,ETV1, andETV4on whole-mount radical prostatectomy tissue
Zhichun Lu et al.
PROSTATE (2020)
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancer
Longjiang Shao et al.
PROSTATE (2020)
Genomic basis for RNA alterations in cancer
Claudia Calabrese et al.
NATURE (2020)
Pan-Cancer Analysis Reveals the Diverse Landscape of Novel Sense and Antisense Fusion Transcripts
Neetha Nanoth Vellichirammal et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development
Nallasivam Palanisamy et al.
CLINICAL CANCER RESEARCH (2020)
AR and ERG drive the expression of prostate cancer specific long noncoding RNAs
Annika Kohvakka et al.
ONCOGENE (2020)
Targetable gene fusions and aberrations in genitourinary oncology
Filippo Pederzoli et al.
NATURE REVIEWS UROLOGY (2020)
PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery
Gail P. Risbridger et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2020)
TMPRSS2-ERG activates NO-cGMP signaling in prostate cancer cells
Feng Zhou et al.
ONCOGENE (2019)
A Rich Array of Prostate Cancer Molecular Biomarkers: Opportunities and Challenges
Indu Kohaar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Characterization of the ERG-regulated Kinome in Prostate Cancer Identifies TNIK as a Potential Therapeutic Target
Rachel S. Lee et al.
NEOPLASIA (2019)
Improved detection of gene fusions by applying statistical methods reveals oncogenic RNA cancer drivers
Roozbeh Dehghannasiri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer
Vipul Bhatia et al.
TRENDS IN MOLECULAR MEDICINE (2019)
TMPRSS2-ERG fusions confer efficacy of enzalutamide in an in vivo bone tumor growth model
Louie Semaan et al.
BMC CANCER (2019)
Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer
Balabhadrapatruni V. S. K. Chakravarthi et al.
NEOPLASIA (2019)
An AR-ERG transcriptional signature defined by long-range chromatin interactomes in prostate cancer cells
Zhizhuo Zhang et al.
GENOME RESEARCH (2019)
Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth
Ahmed A. Mohamed et al.
CANCER RESEARCH (2018)
The long tail of oncogenic drivers in prostate cancer
Joshua Armenia et al.
NATURE GENETICS (2018)
TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases
Carine Delliaux et al.
CANCER LETTERS (2018)
Association between TMPRSS2:ERG fusion gene and the prostate cancer: systematic review and meta-analysis
Herney Andres Garcia-Perdomo et al.
CENTRAL EUROPEAN JOURNAL OF UROLOGY (2018)
TMPRSS2-ERG fusion promotes prostate cancer metastases in bone
Rachel Deplus et al.
ONCOTARGET (2017)
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser et al.
NATURE (2017)
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
Miriam S. Butler et al.
ONCOTARGET (2017)
SLC45A3-ELK4 functions as a long non-coding chimeric RNA
Fujun Qin et al.
CANCER LETTERS (2017)
Development of Peptidomimetic Inhibitors of the ERG Gene Fusion Product in Prostate Cancer
Xiaoju Wang et al.
CANCER CELL (2017)
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy
Jeffrey S. Ross et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Androgen receptor signaling in castration-resistant prostate cancer: a lesson in persistence
Isabel Coutinho et al.
ENDOCRINE-RELATED CANCER (2016)
Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry
Jacqueline Fontugne et al.
MODERN PATHOLOGY (2016)
Androgen receptor-related diseases: what do we know?
G. C. Shukla et al.
ANDROLOGY (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer
Antti Ylipaa et al.
CANCER RESEARCH (2015)
Integrative Clinical Genomics of Advanced Prostate Cancer (vol 161, pg 1215, 2015)
Dan Robinson et al.
CELL (2015)
The Molecular Taxonomy of Primary Prostate Cancer
Adam Abeshouse et al.
CELL (2015)
Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling
Paivi Pihlajamaa et al.
ENDOCRINE REVIEWS (2015)
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Mark M. Pomerantz et al.
NATURE GENETICS (2015)
Molecular Profiling of ETS and Non-ETS Aberrations in Prostate Cancer Patients From Northern India
Bushra Ateeq et al.
PROSTATE (2015)
Specific and redundant activities of ETV1 and ETV4 in prostate cancer aggressiveness revealed by co-overexpression cellular contexts
Diana Mesquita et al.
ONCOTARGET (2015)
Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer
Matti Annala et al.
ONCOTARGET (2015)
Landscape of gene fusions in epithelial cancers: seq and ye shall find
Chandan Kumar-Sinha et al.
GENOME MEDICINE (2015)
Discovery of CTCF-Sensitive Cis-Spliced Fusion RNAs between Adjacent Genes in Human Prostate Cells
Fujun Qin et al.
PLOS GENETICS (2015)
Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer
Philip A. Watson et al.
NATURE REVIEWS CANCER (2015)
Quantitative Analysis of ERG Expression and Its Splice Isoforms in Formalin-Fixed, Paraffin-Embedded Prostate Cancer Samples Association With Seminal Vesicle Invasion and Biochemical Recurrence
Rachel M. Hagen et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2014)
The transcriptional programme of the androgen receptor (AR) in prostate cancer
Alastair D. Lamb et al.
BJU INTERNATIONAL (2014)
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
Elena S. Martens-Uzunova et al.
EUROPEAN UROLOGY (2014)
Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours
Brittany C. Parker et al.
JOURNAL OF PATHOLOGY (2014)
TMPRSS2-ERG gene fusions induce prostate tumorigenesis by modulating microRNA miR-200c
J. Kim et al.
ONCOGENE (2014)
Identification of novel TMPRSS2: ERG mechanisms in prostate cancer metastasis: involvement of MMP9 and PLXNA2
T. V. Tian et al.
ONCOGENE (2014)
A Small Molecule Inhibitor of ETV1, YK-4-279, Prevents Prostate Cancer Growth and Metastasis in a Mouse Xenograft Model
Said Rahim et al.
PLOS ONE (2014)
Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer
Shan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
Himisha Beltran et al.
EUROPEAN UROLOGY (2013)
ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
Esther Baena et al.
GENES & DEVELOPMENT (2013)
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Changmeng Cai et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Nucleotide resolution analysis of TMPRSS2 and ERG rearrangements in prostate cancer
Christopher Weier et al.
JOURNAL OF PATHOLOGY (2013)
A New Murine Model of Osteoblastic/Osteolytic Lesions from Human Androgen-Resistant Prostate Cancer
Anais Fradet et al.
PLOS ONE (2013)
Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
Gregoire Robert et al.
PROSTATE (2013)
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu et al.
CANCER DISCOVERY (2013)
Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
Daiana D. Becker-Santos et al.
CARCINOGENESIS (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Christopher E. Barbieri et al.
NATURE GENETICS (2012)
Chimeric Transcript Generated by cis-Splicing of Adjacent Genes Regulates Prostate Cancer Cell Proliferation
Yanmei Zhang et al.
CANCER DISCOVERY (2012)
Overexpression of ETV4 is oncogenic in prostate cells through promotion of both cell proliferation and epithelial to mesenchymal transition
A. Pellecchia et al.
ONCOGENESIS (2012)
ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
Sarah Minner et al.
CLINICAL CANCER RESEARCH (2011)
Confirmation of the Association of TMPRSS2(exon 0):ERG Expression and a Favorable Prognosis of Primary Prostate Cancer
Joost L. Boormans et al.
EUROPEAN UROLOGY (2011)
Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas
Antoun Toubaji et al.
MODERN PATHOLOGY (2011)
Testing mutual exclusivity of ETS rearranged prostate cancer
Maria A. Svensson et al.
LABORATORY INVESTIGATION (2011)
An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
Jindan Yu et al.
CANCER CELL (2010)
FZD4 as a Mediator of ERG Oncogene-Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Santosh Gupta et al.
CANCER RESEARCH (2010)
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
Nallasivam Palanisamy et al.
NATURE MEDICINE (2010)
Androgens Induce Functional CXCR4 through ERG Factor Expression in TMPRSS2-ERG Fusion-Positive Prostate Cancer Cells
Juan Cai et al.
TRANSLATIONAL ONCOLOGY (2010)
Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
Kyung Park et al.
NEOPLASIA (2010)
SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation-Specific Fusion Transcript in Prostate Cancer
David S. Rickman et al.
CANCER RESEARCH (2009)
TMPRSS2-ERG Gene Fusion Is Not Associated with Outcome in Patients Treated by Prostatectomy
Anuradha Gopalan et al.
CANCER RESEARCH (2009)
Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gfene Expression in Castration-Resistant Prostate Cancer
Changmeng Cai et al.
CANCER RESEARCH (2009)
Characterization of ERG, AR and PTEN Gene Status in Circulating Tumor Cells from Patients with Castration-Resistant Prostate Cancer
Gerhardt Attard et al.
CANCER RESEARCH (2009)
Nuclear Receptor-Induced Chromosomal Proximity and DNA Breaks Underlie Specific Translocations in Cancer
Chunru Lin et al.
CELL (2009)
Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
Karin G. Hermans et al.
CLINICAL CANCER RESEARCH (2009)
Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
Brett S. Carver et al.
NATURE GENETICS (2009)
The role of SPINK1 in ETS rearrangement-negative prostate cancers
Scott A. Tomlins et al.
CANCER CELL (2008)
Pleiotropic Biological Activities of Alternatively Spliced TMPRSS2/ERG Fusion Gene Transcripts
Jianghua Wang et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer
Rohit Mehra et al.
CANCER RESEARCH (2008)
Characterization of TMPRSS2 : ETV5 and SLC45A3 : ETV5 gene fusions in prostate cancer
Beth E. Helgeson et al.
CANCER RESEARCH (2008)
TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis
Outi R. Saramaki et al.
CLINICAL CANCER RESEARCH (2008)
Delineation of TMPRSS2-ERG splice variants in prostate cancer
Ying Hu et al.
CLINICAL CANCER RESEARCH (2008)
Chromosomal imbalances, and immunohistochemical loss of heterozygosity, expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate
Olaf Bettendorf et al.
GENES CHROMOSOMES & CANCER (2008)
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2008)
CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone
Sreenivasa R. Chinni et al.
MOLECULAR CANCER RESEARCH (2008)
Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells
H. Makkonen et al.
ONCOGENE (2008)
TMPRSS2-ERG fusion, a common genomic alteration in prostate cancer activates C-MYC and abrogates prostate epithelial differentiation
C. Sun et al.
ONCOGENE (2008)
A causal role for ERG in neoplastic transformation of prostate epithelium
Olga Klezovitch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of the TMPRSS2-ERG gene fusion in prostate cancer
Arul M. Chinnaiyan
NEOPLASIA (2008)
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
J. Clark et al.
ONCOGENE (2008)
Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer
G. Attard et al.
ONCOGENE (2008)
Recurrent gene fusions in prostate cancer
Chandan Kumar-Sinha et al.
NATURE REVIEWS CANCER (2008)
TMPRSS2-ERG fusion heterogeneity in Multifocal prostate cancer: Clinical and biologic implications
Marc Barry et al.
UROLOGY (2007)
Heterogeneity of TMPRSS2 gene rearrangements in multifocal prostate adenocarcinoma: Molecular evidence for an independent group of diseases
Rohit Mehra et al.
CANCER RESEARCH (2007)
Deletion of a small consensus region at 6q15, including the MAP3K7 gene, is significantly associated with high-grade prostate cancers
Wennuan Liu et al.
CLINICAL CANCER RESEARCH (2007)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
ETV1 is a novel androgen receptor-regulated gene that mediates prostate cancer cell invasion
Changmeng Cai et al.
MOLECULAR ENDOCRINOLOGY (2007)
TMPRSS2: ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort
F. Demichelis et al.
ONCOGENE (2007)
TMPRSS2-ERG fusion prostate cancer:: An early molecular event associated with invasion
Sven Perner et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line:: A new perspective for an old model
Kirsten D. Mertz et al.
NEOPLASIA (2007)
TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer
Karin G. Hermans et al.
CANCER RESEARCH (2006)
TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions
Nuno Cerveira et al.
NEOPLASIA (2006)
TMPRSS2:: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
Sven Perner et al.
CANCER RESEARCH (2006)
Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer
Jianghua Wang et al.
CANCER RESEARCH (2006)
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins et al.
CANCER RESEARCH (2006)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Heterogeneity of gleason grade in multifocal adenocarcinorna of the prostate
R Arora et al.
CANCER (2004)
Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens
AM Wise et al.
UROLOGY (2002)
Share Paper
